Lewisy Promotes Migration of Oral Cancer Cells by Glycosylation of Epidermal Growth Factor Receptor

作者: Wei-Ling Lin , Yi-Shiuan Lin , Guey-Yueh Shi , Chuan-Fa Chang , Hua-Lin Wu

DOI: 10.1371/JOURNAL.PONE.0120162

关键词:

摘要: Aberrant glycosylation changes normal cellular functions and represents a specific hallmark of cancer. Lewisy (Ley) carbohydrate upregulation has been reported in variety cancers, including oral squamous cell carcinoma (OSCC). A high level Ley expression is related to poor prognosis patients with However, it unclear how mediates cancer progression. In this study, the role OSCC was explored. Our data showed that upregulated HSC-3 OC-2 lines. Particularly, epidermal growth factor receptor (EGFR) found cells, modification absent upon inhibition synthesis. The absence EGFR weakened phosphorylation AKT ERK response (EGF). Additionally, EGF-triggered migration reduced, but proliferation not affected. stabilized ligand activation. Conversely, accelerated degradation. summary, these results indicate increased cells able promote by modifying which turn stabilizes downstream signaling. Targeting on could have potential therapeutic effect

参考文章(37)
P Boulougouris, J Elder, Epidermal growth factor receptor structure, regulation, mitogenic signalling and effects of activation Anticancer Research. ,vol. 21, pp. 2769- 2775 ,(2001)
K Antoniades, Em Dietrich, Molecularly targeted drugs for the treatment of cancer: oral complications and pathophysiology. Hippokratia. ,vol. 16, pp. 196- 199 ,(2012)
Juan-Juan Liu, Bei Lin, Ying-Ying Hao, Fei-Fei Li, Da-Wo Liu, Yue Qi, Lian-Cheng Zhu, Shu-Lan Zhang, Masao Iwamori, None, Lewis(y) antigen stimulates the growth of ovarian cancer cells via regulation of the epidermal growth factor receptor pathway. Oncology Reports. ,vol. 23, pp. 833- 841 ,(2010) , 10.3892/OR_00000705
Tetsuya Mitsudomi, Yasushi Yatabe, Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer FEBS Journal. ,vol. 277, pp. 301- 308 ,(2010) , 10.1111/J.1742-4658.2009.07448.X
Zahra Madjd, Tina Parsons, Nicholas FS Watson, Ian Spendlove, Ian Ellis, Lindy G Durrant, High expression of Lewis y/b antigens is associated with decreased survival in lymph node negative breast carcinomas. Breast Cancer Research. ,vol. 7, pp. 1- 8 ,(2005) , 10.1186/BCR1305
Benjamin F. Trump, Sen-itiroh Hakomori, Mei Yuan, Qibing Sun, Young S. Kim, Steven H. Itzkowitz, Alka Palekar, Tokio Kaizu, Expression of LeY and Extended LeY Blood Group-related Antigens in Human Malignant, Premalignant, and Nonmalignant Colonic Tissues Cancer Research. ,vol. 46, pp. 5985- 5992 ,(1986)
Mansoor N. Saleh, Steve Sugarman, James Murray, Joy B. Ostroff, Diane Healey, Dennie Jones, Carol R. Daniel, Donna LeBherz, Hannah Brewer, Nicole Onetto, Albert F. LoBuglio, Phase I Trial of the Anti–Lewis Y Drug Immunoconjugate BR96-Doxorubicin in Patients With Lewis Y–Expressing Epithelial Tumors Journal of Clinical Oncology. ,vol. 18, pp. 2282- 2292 ,(2000) , 10.1200/JCO.2000.18.11.2282
Christine Le Roy, Jeffrey L Wrana, None, Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling Nature Reviews Molecular Cell Biology. ,vol. 6, pp. 112- 126 ,(2005) , 10.1038/NRM1571
Jennifer A. Westwood, William K. Murray, Melanie Trivett, Nicole M. Haynes, Benjamin Solomon, Linda Mileshkin, David Ball, Michael Michael, Angela Burman, Preethi Mayura-Guru, Joseph A. Trapani, Stefan Peinert, Dirk Hönemann, H. Miles Prince, Andrew M. Scott, Mark J. Smyth, Phillip K. Darcy, Michael H. Kershaw, The Lewis-Y carbohydrate antigen is expressed by many human tumors and can serve as a target for genetically redirected T cells despite the presence of soluble antigen in serum. Journal of Immunotherapy. ,vol. 32, pp. 292- 301 ,(2009) , 10.1097/CJI.0B013E31819B7C8E